Literature DB >> 26732857

Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases.

Kimia T Maleki1, Martin Cornillet1, Niklas K Björkström2.   

Abstract

SEMA4D/CD100 is a homodimeric protein belonging to the semaphorin family of axonal guidance proteins. Semaphorin family members have received increased attention lately due to their diverse functions in the immune system. SEMA4D was the first semaphorin described to have immune functions and serves important roles in T cell priming, antibody production, and cell-to-cell adhesion. Proteolytic cleavage of SEMA4D from the cell surface gives rise to a soluble fragment of SEMA4D (sSEMA4D). Similar to the transmembranal form, sSEMA4D is thought to have immunoregulatory properties. While the exact mechanisms responsible for SEMA4D shedding remain to be elucidated, emerging data have revealed associations between elevated systemic sSEMA4D levels and severity of infectious and inflammatory diseases. This review summarizes the literature concerning sSEMA4D and discusses its potential as a novel prognostic immune-biomarker and potential target for immunotherapy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Biomarker; CD100/SEMA4D; Immunoregulator; Immunotherapy; Soluble CD100/soluble SEMA4D

Mesh:

Substances:

Year:  2015        PMID: 26732857     DOI: 10.1016/j.clim.2015.12.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  19 in total

1.  Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer.

Authors:  Wu-Gui Chen; Jing Sun; Wei-Wei Shen; Si-Zhen Yang; Ying Zhang; Xu Hu; Hao Qiu; Shang-Cheng Xu; Tong-Wei Chu
Journal:  Clin Exp Metastasis       Date:  2019-01-07       Impact factor: 5.150

2.  Locally Secreted Semaphorin 4D Is Engaged in Both Pathogenic Bone Resorption and Retarded Bone Regeneration in a Ligature-Induced Mouse Model of Periodontitis.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Kenta Yamamoto; Tsuguno Yamaguchi; Alireza Heidari; Roodelyne Pierrelus; Elizabeth Leon; Satoru Shindo; Mohamad Rawas-Qalaji; Maria Rita Pastore; Atsushi Ikeda; Shin Nakamura; Hani Mawardi; Umadevi Kandalam; Patrick Hardigan; Lukasz Witek; Paulo G Coelho; Toshihisa Kawai
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

3.  Insufficient CD100 shedding contributes to suppression of CD8+ T-cell activity in non-small cell lung cancer.

Authors:  Hong-Min Wang; Xiao-Hong Zhang; Li-Qun Ye; Kai Zhang; Ning-Ning Yang; Shen Geng; Jing Chen; Shun-Xin Zhao; Kang-Li Yang; Fei-Fei Fan
Journal:  Immunology       Date:  2020-04-07       Impact factor: 7.397

4.  Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D.

Authors:  Kou Motani; Hidetaka Kosako
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

5.  Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation.

Authors:  Xiaojun Jiang; Niklas K Björkström; Espen Melum
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

6.  Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?

Authors:  Nadav Willner; Yair Goldberg; Elad Schiff; Zahava Vadasz
Journal:  ESC Heart Fail       Date:  2018-03-10

Review 7.  CD100 Effects in Macrophages and Its Roles in Atherosclerosis.

Authors:  Maria C A Luque; Mariana K Galuppo; Janaina Capelli-Peixoto; Beatriz S Stolf
Journal:  Front Cardiovasc Med       Date:  2018-09-28

8.  Sema4D Aggravated LPS-Induced Injury via Activation of the MAPK Signaling Pathway in ATDC5 Chondrocytes.

Authors:  Jinlai Lei; Yahui Fu; Yan Zhuang; Kun Zhang
Journal:  Biomed Res Int       Date:  2020-04-25       Impact factor: 3.411

9.  Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.

Authors:  Roshanak Derakhshandeh; Sonia Sanadhya; Kyu Lee Han; Haiyan Chen; Olga Goloubeva; Tonya J Webb; Rania H Younis
Journal:  Oncotarget       Date:  2018-01-19

10.  CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Authors:  Rafael Correa-Rocha; Jacobo Lopez-Abente; Carolina Gutierrez; Verónica Astrid Pérez-Fernández; Adrián Prieto-Sánchez; Santiago Moreno-Guillen; María-Ángeles Muñoz-Fernández; Marjorie Pion
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.